Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease

Epstein Barr virus (EBV)(+) Hodgkin's disease (HD) expresses clearly identified tumor antigens derived from the virus and could, in principle, be a target for adoptive immunotherapy with viral antigen–specific T cells. However, like most tumor-associated antigens in immunocompetent hosts, these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bollard, Catherine M., Aguilar, Laura, Straathof, Karin C., Gahn, Benedikt, Huls, M. Helen, Rousseau, Alexandra, Sixbey, John, Gresik, M. Victoria, Carrum, George, Hudson, Melissa, Dilloo, Dagmar, Gee, Adrian, Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.
Formato: Artigo
Idioma:Inglês
Publicado em: The Rockefeller University Press 2004
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2211993/
https://ncbi.nlm.nih.gov/pubmed/15611290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20040890
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados